Close menu




April 17th, 2026 | 07:20 CEST

Sell Nordex? Verbio Faces Analyst Skepticism - Dividend Gem RE Royalties at a Strategic Turning Point

  • royalties
  • dividends
  • renewableenergy
  • biofuels
Photo credits: AI

A major development at RE Royalties. Management is responding to the clear undervaluation and is reviewing all strategic options, including a potential sale. The move appears justified, as the dividend yield of around 10% seems unusually high. The stock could arguably be trading at significantly higher levels. Is a revaluation now on the horizon? What kind of momentum can be unleashed has already been demonstrated by Nordex and Verbio. Both stocks have performed extremely well in recent months. However, analysts are now turning more cautious. At Nordex, order intake is declining, while something unusual stands out in analyst commentary on Verbio.

time to read: 3 minutes | Author: Fabian Lorenz
ISIN: RE ROYALTIES LTD | CA75527Q1081 | TSXV: RE , OTCQX: RROYF , NORDEX SE O.N. | DE000A0D6554 , VERBIO VER.BIOENERGIE ON | DE000A0JL9W6

Table of contents:


    RE Royalties: Revaluation Overdue

    Strong cash flows from renewable energy production and an attractive dividend—yet RE Royalties remains a hidden gem. The stock offers not only upside potential but also a dividend yield of around 10%.

    The term "royalties" still evokes associations with mining for many investors. But RE Royalties is changing that. The business model: Project developers receive capital without giving up equity. In return, RE Royalties receives a share of future revenues. The company exclusively finances proven technologies such as solar, wind, hydroelectric power, and energy storage. Thanks to numerous projects in the US, RE Royalties is benefiting from the AI boom. The company's project pipeline, valued at CAD 20 million, now has a potential volume of up to CAD 200 million. This is because the rapidly growing number of data centers often faces outdated grids and limited power supply. As a result, decentralized solutions such as wind, solar, and storage projects are gaining significant importance.

    Management is responding to the discrepancy between market capitalization and corporate performance. The strategic direction is currently under intensive review. To optimize shareholder value, all options are on the table: partnerships, new financing structures, and even the sale of the entire company.

    Against this backdrop, things are likely to get exciting on May 20, 2026, when COO Peter Leighton will be presenting live at the International Investment Forum (IIF). Registration for the virtual investor conference is free for investors.

    Register for free for the International Investment Forum on May 20, 2026

    Nordex: Order intake declines, sell the stock?

    While there are many factors pointing to rising prices for RE Royalties, the price rally at Nordex is stalling. At least, that is the view of mwb research. The analysts downgraded the wind turbine manufacturer's stock to "Sell" following the release of Q1 order intake figures.

    Following a record year, order intake was weaker in the first three months of the current year. The company reported a 14% decline in new orders to 1.9 GW. Analysts expect this trend to continue throughout the year.

    Furthermore, the mwb experts are more cautious than their colleagues in their outlook on the Q1 figures. They expect Nordex to report only a revenue increase of up to 2% on April 27. The consensus expects a 9% increase compared to the same quarter last year. Regarding EBITDA, mwb expects Nordex to report between EUR 100 and EUR 120 million. The consensus here is EUR 113 million. Overall, analysts consider the company's full-year forecast, revenue of EUR 8.2 to 9.0 billion and an EBITDA margin of 8% to 11%, to be realistic.

    The reason for the "Sell" recommendation is the high valuation. From the experts' perspective, the roughly 50% price rally since the start of the year has shifted the risk-return profile too sharply. With a P/E ratio of 26 for the current year, the stock is too expensive given the geopolitical uncertainty. Analysts see the fair value at EUR 40. The stock is currently trading just above EUR 46.

    Verbio: What is going on with the analysts?

    Verbio has been a standout performer in recent weeks. The stock of this biofuel provider has gained over 78% since the start of 2026 alone. Since October 2025, the stock has more than tripled in value.

    Here, too, analysts expect the price rally to come to an end. Jefferies has raised its price target for Verbio from EUR 21 to EUR 25. An upward revision of the forecast for the current year is certainly possible. However, Verbio shares are trading just under EUR 40. Therefore, analysts recommend a "Hold." Why they couldn't bring themselves to issue a "Sell" recommendation given the large gap between the price target and the current price remains their secret.

    At Deutsche Bank, too, the recommendation and price target do not quite align. They have raised their price target from EUR 29.60 to EUR 40.50. Given the current price, one might expect a "Hold" recommendation, but that is not the case. The analysts recommend a "Buy".


    A revaluation is overdue for RE Royalties. Regardless of the outcome of the review, the stock should react positively. Adding a few shares to your portfolio could be worthwhile, especially since the dividend provides a floor for the price. At Nordex, investors are accustomed to high returns but will likely have to brace for a somewhat quieter year. Verbio is likely to continue benefiting from high gasoline prices, but is also already ambitiously valued.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Fabian Lorenz

    For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

    About the author



    Related comments:

    Commented by Fabian Lorenz on June 23rd, 2026 | 07:15 CEST

    Nordex Surges Higher! Sharp Revenue Decline at thyssenkrupp nucera! Is dynaCERT a Buy Now?

    • cleantech
    • Hydrogen
    • greenhydrogen
    • renewableenergy

    Nordex appears to have completed its consolidation phase. Following a sharp correction, the wind turbine manufacturer's stock has rebounded strongly in recent weeks. Yesterday, orders from the US provided fresh momentum. Investors could also speculate on a significant share price recovery driven by new orders at dynaCERT. The cleantech company's stock has corrected significantly in recent weeks. The German management team has focused on series production and sales in recent months, which should bear fruit in the second half of the year. Analysts are certainly bullish. There is also a "Buy" recommendation for thyssenkrupp nucera. However, the most recent quarterly report has caused some disillusionment. While order intake was positive, the revenue decline was quite dramatic.

    Read

    Commented by Tarik Dede on June 23rd, 2026 | 07:10 CEST

    Royalties & licensing: investors can win with ARM Holdings, RE Royalties and Franco-Nevada!

    • royalties
    • cleantech
    • dividends

    You can build business models with high margins without owning a single factory or site. On the capital markets, that's mainly companies that collect license fees or royalties. Companies provide capital and in return share in their partner's revenue. This has long been the case in the music industry, and likewise in mining, the chip industry, the cleantech sector and the pharmaceutical industry. For investors, such companies offer big advantages, since in most cases they carry little or no operating risk. Because the contracts often run for years or decades, the income they generate is also very stable. While mining and cleantech players tend to offer steady payouts, tech pioneers use the cash flow for massive growth. Today we therefore look at the shares of ARM Holdings, RE Royalties and Franco-Nevada!

    Read

    Commented by Nico Popp on June 22nd, 2026 | 06:35 CEST

    Verbio, E.ON, and A.H.T. Syngas: Market Leaders and Challengers

    • syngas
    • biochar
    • renewableenergy
    • Energy
    • cleantech

    The recent energy price shock and regulatory requirements are accelerating the transition to low-carbon alternatives to fossil fuels. As a result, the energy industry is transforming. To achieve the industry's ambitious decarbonization goals, energy providers are increasingly focusing on modular systems for utilizing biogenic residues. Major market leaders are increasingly securing technological scalability through acquisitions, as building green business models organically is a lengthy and risky process. Multi-billion-dollar acquisitions in the biomass and biogas sectors are driving a wave of consolidation. Decentralized solutions for generating baseload electricity and hydrogen have long been a key pillar of the energy transition. We highlight three companies.

    Read